Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Drop in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 46,800 shares, a drop of 53.3% from the October 31st total of 100,200 shares. Based on an average daily volume of 504,700 shares, the days-to-cover ratio is currently 0.1 days. Approximately 7.5% of the company’s shares are short sold.

Analyst Upgrades and Downgrades

Separately, LADENBURG THALM/SH SH assumed coverage on shares of Autonomix Medical in a research note on Tuesday, September 3rd. They set a “buy” rating and a $28.00 price target for the company.

Autonomix Medical Trading Down 10.4 %

Shares of AMIX stock traded down $0.57 during trading hours on Friday, reaching $4.92. The company had a trading volume of 263,940 shares, compared to its average volume of 226,942. Autonomix Medical has a 1-year low of $4.82 and a 1-year high of $152.00. The company has a debt-to-equity ratio of 0.36, a current ratio of 4.26 and a quick ratio of 4.26. The firm has a market cap of $5.66 million and a price-to-earnings ratio of -0.32. The company has a 50 day moving average of $10.99 and a 200 day moving average of $19.17.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.